Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martine Sinet

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2009
Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?Cécile Goujard, Marie-Laure Chaix, Olivier Lambotte, et al.
The Journal of Infectious Diseases|February 25, 2003
Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infectionChristine Lacabaratz-Porret, Alejandra Urrutia, Jean-Marc Doisne, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2007
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotypeAsier Sáez-Cirión, Christine Lacabaratz, Olivier Lambotte, et al.
AIDS (London, England)|July 21, 2009
Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cellsCamille Lécuroux, Isabelle Girault, François Boutboul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2006
CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patientsCécile Goujard, Mojgan Bonarek, Laurence Meyer, et al.
Antiviral Therapy|August 7, 2012
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapyCécile Goujard, Isabelle Girault, Christine Rouzioux, et al.
Journal of Virology|October 18, 2013
Both HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllersCamille Lécuroux, Asier Sáez-Cirión, Isabelle Girault, et al.
Plos One|October 12, 2012
Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infectionAnne-Sophie Liovat, Marie-Anne Rey-Cuillé, Camille Lécuroux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responsesAsier Sáez-Cirión, Martine Sinet, So Youn Shin, et al.
Journal of Virology|October 12, 2007
Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 studySimon J Potter, Christine Lacabaratz, Olivier Lambotte, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 18, 2009
Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?Cécile Goujard, Marie-Laure Chaix, Olivier Lambotte, et al.
The Journal of Infectious Diseases|February 25, 2003
Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infectionChristine Lacabaratz-Porret, Alejandra Urrutia, Jean-Marc Doisne, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2007
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotypeAsier Sáez-Cirión, Christine Lacabaratz, Olivier Lambotte, et al.
AIDS (London, England)|July 21, 2009
Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cellsCamille Lécuroux, Isabelle Girault, François Boutboul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2006
CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patientsCécile Goujard, Mojgan Bonarek, Laurence Meyer, et al.
Antiviral Therapy|August 7, 2012
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapyCécile Goujard, Isabelle Girault, Christine Rouzioux, et al.
Journal of Virology|October 18, 2013
Both HLA-B*57 and plasma HIV RNA levels contribute to the HIV-specific CD8+ T cell response in HIV controllersCamille Lécuroux, Asier Sáez-Cirión, Isabelle Girault, et al.
Plos One|October 12, 2012
Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infectionAnne-Sophie Liovat, Marie-Anne Rey-Cuillé, Camille Lécuroux, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responsesAsier Sáez-Cirión, Martine Sinet, So Youn Shin, et al.
Journal of Virology|October 12, 2007
Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 studySimon J Potter, Christine Lacabaratz, Olivier Lambotte, et al.
Pageof 2